Close Menu

After the Sequence

At the Loom, Carl Zimmer bemoans what he dubs the "Yet-Another-Genome Syndrome." Sequencing a genome, he writes, used to be different — it took forever to do and was a big deal when it came out — but with next-generation sequencing, it takes comparatively no time at all, yet they still generate tons of press releases and news articles. It's what comes after the sequencing, Zimmer says, that is interesting.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.